norm: taro pharmaceuticals usaUSLEI 5493004JREQ36RTDB661 · no CIKMax severity: High

Canonical registry

Taro Pharmaceuticals U.S.A., Inc.

ent_019e6156d546dca9b0f290a0308ed09d

Compliance scorecard →🔔 Follow entity

Disclosures

1

State AG · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

1,734

as filed · State AG ME

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Taro Pharmaceuticals U.S.A., Inc.
Normalized: taro pharmaceuticals usa— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: 5493004JREQ36RTDB661
SEC EDGAR CIK: None — not an SEC registrant
Domain: None on record

Disclosure history (1)newest first

🦞Maine State AGas victim2023-04-21
Taro Pharmaceuticals U.S.A., Inc. reported an external system breach (hacking) occurring on March 3, 2023, discovered on March 25, 2023. The incident affected 1,734 individuals, including one Maine resident. Personal information compromised included names and Social Security Numbers. Taro provided written notification on April 19, 2023, and offered 24 months of credit monitoring through TransUnion.